Before becoming Chief Product Officer, Gary was Ultromics' Head of Research and Development, responsible for global R&D activities including end-to-end management of technology development, transfer, and IP.
Gary maintains an honorary lectureship in diagnostics at University College London and holds Honorary Clinical Scientist roles within the NHS, with continued clinical state registration. He is also a member of the Royal College of Pathologists.
Prior to joining Ultromics, Gary led innovation in biliary disease products at Perspectum Diagnostics, playing a key role in FDA clearance, market entry, research, and partnering activities. He has also held senior scientific positions across healthcare, including Oxford University Hospitals, and the pharmaceutical sector, including GlaxoSmithKline, where he helped bring numerous diagnostic solutions to market.
